Generic and Biosimilar Medicines Industry – Opportunities and Challenges, Outlook and Sustainability
Generic and Biosimilar Medicines Industry – Opportunities and Challenges, Outlook and Sustainability

Author(s): Plamen Pouvkov
Subject(s): Social Sciences, Economy, Supranational / Global Economy, Sociology, Health and medicine and law
Published by: Университет за национално и световно стопанство (УНСС)
Keywords: Generic Medicines; Biosimilar Medicines; Pharma Industry; Pharma 4.0; Clinical Trials
Summary/Abstract: It has been years and decades since the Generic industry, and the Biosimilar industry later on, has started paving its way to become a substantial factor for the healthcare systems around the globe. The main drives for this important role of the industry are found in the enhancement of the reach and access to high quality but less expensive cost-effective therapies. Thus, the industry is making a significant and global impact on the health outcomes – through economic effects of reduced and more affordable costs to extend and in some cases allow the reach and access to existing therapies, and also allow for the respective savings to be allocated towards newly developed innovative therapies.

• Details
• Contents